Ligand validation:6B6F

9F2: Ceftriaxone

9F2 is a Ligand Of Interest in 6B6F designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6B6F_9F2_A_301	27%	6%	0.187	0.834	2.1	3.01	9	14	1	0	100%	0.65
6B68_9F2_D_400	65%	7%	0.127	0.929	1.93	2.91	9	15	2	0	100%	0.86
6B5Y_9F2_D_400	63%	5%	0.153	0.949	1.84	3.35	7	19	0	0	100%	0.92
6B6A_9F2_D_301	56%	5%	0.144	0.916	1.8	3.46	7	15	1	0	100%	0.8
7K8H_9F2_D_301	55%	4%	0.167	0.935	1.93	3.8	12	14	0	0	100%	0.792
6B69_9F2_D_301	39%	6%	0.18	0.885	1.96	3.06	11	14	0	0	100%	0.55
6XQV_9F2_A_601	63%	18%	0.129	0.924	0.87	2.64	1	9	0	0	100%	1
5NZX_9F2_A_1102	59%	46%	0.152	0.933	0.9	1.16	2	2	1	0	100%	1
8YXB_9F2_A_601	55%	14%	0.135	0.903	1.51	2.29	6	8	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.